You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 4, July 27, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic

Vitamin E Supplementation, Cardiovascular Events, and Cancer

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In 1950, Vogelsang1 reported that intramuscular administration of {alpha}-tocopherol produced rapid and dramatic diuresis in patients with severe heart failure. Dr Lonn and colleagues have now shown that long-term supplementation with {alpha}-tocopherol increases the risk of developing heart failure.2 These findings are not necessarily incompatible.

Vitamin E occurs in food in 4 different forms ({alpha}-, {beta}-, {gamma}-, and {delta}-tocopherol), but most of the clinical research has been performed with {alpha}-tocopherol alone. Although early research suggested that most of the biological activity of vitamin E resides in the {alpha}-fraction, {gamma}-tocopherol has certain effects that might help prevent cardiovascular disease. Platelet aggregation and the formation of nitric-oxide–derived oxidants are inhibited to a greater extent by {gamma}-tocopherol than by {alpha}-tocopherol.3 Treatment with large doses of {alpha}-tocopherol reduces serum concentrations of {gamma}-tocopherol (apparently by accelerating its metabolism),4 and could thereby interfere with these effects.

{gamma}-Tocopherol comprises 70% of the vitamin . . . [Full Text of this Article]

Alan R. Gaby, MD
drgaby@earthlink.net
Carlisle, Pa


RELATED ARTICLES

Vitamin E Supplementation, Cardiovascular Events, and Cancer
Robert M. Richey
JAMA. 2005;294(4):425.
EXTRACT | FULL TEXT  

Vitamin E Supplementation, Cardiovascular Events, and Cancer
Robert W. Jarski, Kenneth R. Hightower, and Michael I. Dangovian
JAMA. 2005;294(4):425-426.
EXTRACT | FULL TEXT  

Vitamin E Supplementation, Cardiovascular Events, and Cancer—Reply
Eva Lonn
JAMA. 2005;294(4):426.
EXTRACT | FULL TEXT  

Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial
The HOPE and HOPE-TOO Trial Investigators
JAMA. 2005;293(11):1338-1347.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.